ASTRO 2021: EBRT Underused in Patients With Liver Cancer Awaiting Transplant
Less than 4% of patients are prescribed this noninvasive bridging option.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Less than 4% of patients are prescribed this noninvasive bridging option.
Only registered members have full access to PracticeUpdate content.